Marlene Debel - Feb 23, 2023 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Role
Director
Signature
/s/ Marlene Debel by Jonathan J. Doyle as Attorney-in-Fact
Stock symbol
RJF
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
4
Date filed
2/27/2023, 10:19 AM
Previous filing
Aug 23, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RJF Common Stock Options Exercise $0 +1.68K +66.52% $0.00 4.21K Feb 23, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RJF Restricted Stock Units Award $0 +1.64K +97.62% $0.00 3.33K Feb 23, 2023 Common Stock 1.64K Direct F1, F2
transaction RJF Restricted Stock Units Options Exercise $0 -1.68K -50.6% $0.00 1.64K Feb 23, 2023 Common Stock 1.68K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2 The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2024.
F3 The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of RSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.